Trial Profile
A phase II trial to investigate the efficacy and safety of CTP 354 in patients with spasticity associated with spinal cord injury
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2014
Price :
$35
*
At a glance
- Drugs CTP 354 (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 06 Aug 2014 New trial record